in Re: Children's Medical Center of Dallas

CourtCourt of Appeals of Texas
DecidedMay 18, 2022
Docket05-22-00459-CV
StatusPublished

This text of in Re: Children's Medical Center of Dallas (in Re: Children's Medical Center of Dallas) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
in Re: Children's Medical Center of Dallas, (Tex. Ct. App. 2022).

Opinion

Dissent and Opinion Filed May 18, 2022

In The Court of Appeals Fifth District of Texas at Dallas No. 05-22-00459-CV

IN RE CHILDREN’S MEDICAL CENTER OF DALLAS, Relator

Original Proceeding from County Court at Law No. 2 Dallas County, Texas Trial Court Cause No. CC-22-02427-13

DISSENTING OPINION Opinion by Justice Schenck In this original proceeding, Relator Children’s Medical Center of Dallas

(“Hospital”) seeks to dissolve the trial court’s order granting real party in interest

Ximena Lopez, M.D.’s (“Doctor”) application of temporary restraining order on the

ground that it does not specifically describe the imminent and irreparable harm

Doctor will sustain in the absence of the order. Because I believe the trial court

abused its discretion, I respectfully dissent from the majority’s denial of the

Hospital’s petition and its conclusion the Hospital has failed to establish it is entitled

to mandamus relief. BACKGROUND

Doctor is a pediatric neurooncologist who treats patients at the University of

Texas Southwestern Medical Center (“UTSW”) and the Hospital. In 2012, Doctor

helped to create the Gender Education and Care Interdisciplinary Support

(“GENECIS”) program, which describes itself as providing gender-affirming care

for gender diverse and transgender adolescence.

Doctor alleges that in 2021 the Hospital informally informed her that her

gender-affirming endocrinology care via the GENECIS program could continue as

to existing patients, but not to new ones. On March 28, 2022, the Hospital and

UTSW issued a joint statement publicly announcing their decision to suspend

initiating hormone treatment as a component of care for new pediatric patients

treated for gender dysphoria, based on their concern, due to certain public statements

of the governor and attorney general on the matter, that a failure to act would put the

entire GENECIS program in jeopardy. Care for existing patients would remain

unchanged, and new patients would still have access to the broader array of gender-

affirming care provided, including psychiatric care for gender transition and other

services necessary for evaluation of potential gender dysphoria.

On May 11, 2022, Doctor filed the underlying suit against the Hospital,

seeking, in part, a declaratory judgment that the Hospital’s action concerning the

GENECIS program: (i) “violates laws prohibiting the corporate practice of medicine

and limitations on physician’s exercise of independent judgment in the exercise of

–2– their clinical privileges;” and (ii) “is illegal discrimination.” Doctor also sought a

temporary restraining order, a temporary injunction, and permanent injunction.

During the afternoon of May 11, 2022, the trial court held a hearing on Doctor’s

application for a temporary restraining order. On May 12, 2022, the trial court

signed a temporary restraining order providing the following restraints.

a. [Hospital] and its officers, agents, servants, employees, attorneys, as well as any individuals and entities in active concert or participation with them who receive actual notice of the order by personal service or otherwise are restrained during the pendency of this Order from enforcing any policy or limitation that restricts or prohibits gender-affirming endocrinology care, including specifically pubertal suppression or hormone therapy, to new or established patients due the patient’s gender identity or gender dysphoria;

b. [Hospital] and its officers, agents, servants, employees, attorneys, as well as any individuals and entities in active concert or participation with them who receive actual notice of the order by personal service or otherwise are restrained during the pendency of this Order from discriminating against patients seeking gender-affirming endocrinology care by restricting or prohibiting care because of the patient’s gender identity;

c. [Hospital] and its officers, agents, servants, employees, attorneys, as well as any individuals and entities in active concert or participation with them who receive actual notice of the order by personal service or otherwise are restrained from interfering with, controlling, or otherwise directing any physician’s professional judgment with respect to the provision of gender-affirming endocrinology care at [Hospital]; and

d. [Hospital] and its officers, agents, servants, employees, attorneys, as well as any individuals and entities in active concert or participation with them who receive actual notice of the order by personal service or otherwise are restrained from imposing any –3– limitation on [Doctor’s] exercise of her clinical privileges to provide pediatric endocrinology care, including, but not limited to, prohibiting her from providing gender-affirming endocrinology care, in the absence of any formal due process under [Hospital’s] by-laws by the appropriate parties to restrict [Doctor’s] clinical privileges.

On May 13, 2022, the Hospital filed this original proceeding.

AVAILABILITY OF MANDAMUS RELIEF

Entitlement to mandamus relief requires the relator to show that the trial court

has clearly abused its discretion and that relator has no adequate appellate remedy.

In re Prudential Ins. Co., 148 S.W.3d 124, 135–36 (Tex. 2004) (orig. proceeding).

Whether a clear abuse of discretion can be adequately remedied by appeal depends

on a careful analysis of the costs and benefits of interlocutory review. In re McAllen

Med. Ctr., Inc., 275 S.W.3d 458, 464 (Tex. 2008) (orig. proceeding) (citing In re

Prudential Ins. Co., 148 S.W.3d 124, 136 (Tex. 2004) (orig. proceeding)). When

reviewing a temporary restraining order for defects that would render it void, “[a]

trial court abuses its discretion when it issues a void order.” In re Elevacity, LLC,

No. 05-18-00135-CV, 2018 WL 915031, at *1–2 (Tex. App.—Dallas Feb. 16, 2018,

orig. proceeding) (mem. op.) (granting mandamus relief based on finding that

temporary restraining order was void for failure to comply with Rules 680, 683, and

684).

Mandamus review of a trial court’s temporary restraining order is proper

because such an order cannot be appealed and, thus, the party against whom such

injunctive relief is granted lacks an adequate remedy by appeal. See, e.g., In re

–4– Office of Attorney Gen., 257 S.W.3d 695, 698 (Tex. 2008) (orig. proceeding) (per

curiam) (“Because temporary restraining orders are not appealable, the Attorney

General has no remedy by appeal.”); Elevacity, 2018 WL 915031, at *1 (“Because

temporary restraining orders are not appealable, there is no remedy by appeal.”).

DISCUSSION

Texas Rule of Civil Procedure 683 states that a temporary restraining order

“shall set forth the reasons for its issuance” and “shall be specific in its terms.” TEX.

R. CIV. P. 683 (emphasis added); see also El Tacaso, Inc. v. Jireh Star, Inc., 356

S.W.3d 740, 744 (Tex. App.—Dallas 2011, no pet.) (“A trial court’s order stating its

reasons for granting a temporary injunction must be specific and legally sufficient

on its face and not merely conclusory. To comply with rule 683, a trial court must

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Prudential Insurance Co. of America
148 S.W.3d 124 (Texas Supreme Court, 2004)
In Re Office of the Attorney General
257 S.W.3d 695 (Texas Supreme Court, 2008)
In Re McAllen Medical Center, Inc.
275 S.W.3d 458 (Texas Supreme Court, 2008)
East Texas Medical Center Cancer Institute v. Anderson
991 S.W.2d 55 (Court of Appeals of Texas, 1998)
Tenet Health Ltd. v. Zamora
13 S.W.3d 464 (Court of Appeals of Texas, 2000)
Christopher Daniel Duntsch v. State
568 S.W.3d 193 (Court of Appeals of Texas, 2018)
El Tacaso, Inc. v. Jireh Star, Inc.
356 S.W.3d 740 (Court of Appeals of Texas, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
in Re: Children's Medical Center of Dallas, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-childrens-medical-center-of-dallas-texapp-2022.